chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hospitalized 1/2/2022-still currently admitted; transferred to hospital on 1/4/2022;  COVID-19 positive 1/2/2022; fully vaccinated  HISTORY OF PRESENT ILLNESS: Patient is a 47 y.o. male who presents as a transfer from Hospital. Past medical history of hodgkin's lymphoma, recent diagnosis of cecal adenocarcinoma, and GERD. Patient presented on 1/2/22 with complaint of lower extremity weakness. Patient states he got up during the early morning on 1/2/22 to use the bathroom. After sitting for a minute, he was unable to stand up from the toilet. He attempted to stand, but his legs were weak and buckled under him. Both legs were weak, but the right seemed to be notably more weak than the left. At that time he also noted his right upper lip and nasal fold felt numb. Prior to this weakness episode, patient he had been having some fatigue, stomach cramps, vomiting, lack of appetite, and head congestion. These symptoms all began on 12/29/21.  Covid-19 -stable on RA -symptoms began 6 days ago -can hold on decadron. Start if any signs of clinical worsening  -Mucinex PRN congestion  -check CRP 1/11/2022 note: 1. New onset weakness Resolved. Appreciate neurology input. CSF shows a total protein of 88 which is mildly elevated from the baseline and less than 50 wbc's. Responded to 5 doses of IVIG for suspected AIDP.    2. Post lumbar puncture headache. Resolved with hydration.   3.COVID 19 Has been fully vaccinated. Stable on room air. Does not have any respiratory symptoms at this time. Will hold Decadron and remdesivir at this time.   .4.Liver lesions concerning for metastatic liver disease. Appreciate input from Oncology.   5. Recent history of cecal adenocarcinoma.   Status post resection in December.  Appreciate input from Oncology..   6. Lymphadenopathy versus carotid body tumor of right neck Appreciate input from Oncology. 7. Right calf tenderness Doppler shows right calf DVT in the right peroneal and tibial veins. Started on Lovenox therapeutic dose. Appreciate Heme input. Per notes appears to be waiting on Ultrasound 1/13/2022 and PET scan.
Pt. received Tdap vaccine on 9/5/08. About 1 hr. later she c/o headache. Within 8 hrs she was feeling weak, lightheaded, & dizzy, with her headache worsening for the next 2 days. Pt. also had joint pain in elbows, knees, & neck. She c/o nausea & diarrhea starting on 9/7. Today, 9/8, she still has slight nausea & diarrhea, weakness, tiredness, & dizziness.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Patient fainted for about 5 seconds and then recovered-Mild, Systemic: Flushed / Sweating-Mild
Seen on 8/30/04 for CHS appointment at 8:15. DOB 7/7/04 per forms completed by mother. Given immunization at end of visit. After sots mother reported to RN at DOB was 8/7/04. TC to mother on 8/31. Reports child had a seizure late Monday and was taken to hospital. Child at home now and doing fine.
Information has been received from a physician concerning an "over 70 years old" female who was vaccinated on an unspecified date with zoster vaccine live (Oka/Merck) at the pharmacy. Subsequently, 10 to 12 days later the patient developed shingles. Unspecified medical attention was sought in the Emergency Room. The patient was not admitted. At the time of the report the patient's status was unknown. There was no product quality complaint involved. Additional information has been requested.
Within 72 Hours of my vaccine I experienced fatigue, left arm soreness, body aches, and beginning to have hot flashes that would come and go. A week after, I experienced spotting and then heavy bleeding including clotting for almost about a month. I had experienced that again after a short break and then it came back for another month.   I did have hot flashes post second vaccination as well.
at time of 1st vaccine felt ache soreness, has not abated .  limited range of motion of the shoulder.
She still has the symptoms as of today. The first day, Saturday was more like a cold and feeling unwell-runny nose, congestion, coughing, sinus headache which she figured was allergies. Sunday, vomiting, diarrhea chills, lots of coughing and sniffling. That continued on and she got on Paxlovid antiviral and threw it up later that night. The past 2 days fever, chills, oxygen level fluctuates between low 90 and high 97. She felt a little better this morning initially but then fever and chills and exhaustion came back and she is pretty tired and has a hard time taking a deep breath, and headache.
patient came in on 11/10/2022 at around 5pm showing her left arm and saying that it is swollen and not getting better, but not getting worst either. she is going to see a doctor.  left arm site of injection did look swallow and little circular blue spot, but not radiating, not swelling beyond site of injection. I asked if it's painful, she stated a little.  I recommended some Motrin or Tylenol  and follow-up with md.
Information has been received from a woman working at a hospital concerning a female, with a penicillin allergy and hypertension, who was vaccinated with a first series of hepatitis B virus vaccine rHBsAg (yeast) (manufacturer unknown).  It was reported that the patient did not convert.  Subsequently the patient was vaccinated with a second series of RECOMBIVAX HB.  It was reported that following the second series of RECOMBIVAX HB, the titer was positive.  Possible vaccine failure was reported.  The patient also experienced a negative titer following vaccination with a dose of VAQTA (MSD) (WAES# 0506USA02299).  Additional information has been requested.
Small rash broke out on back and arms. The rashlooks almost like bumps right before a pimple forms, small and hard, extremely tiny. Not very red. Sporadic around my back only a few down each arm.; At injection site there was a burning sensation a little while after leaving facility; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 01May2021 at 12:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included seizure and known allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lamotrigine (LAMICTAL) and topiramate (MANUFACTUER UNKNOWN); all for unknown indications, from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021, the patient experienced at injection site, there was a burning sensation a little while after leaving facility. On 06May2021, 5 days later, the patient had small rash broke out on back and arms and the rash looked almost like bumps right before a pimple forms, small and hard, extremely tiny, not very red. It was sporadic around back and only a few down each arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events at injection site there was a burning sensation a little while after leaving facility, small rash which broke out on back and arms and the rash looked almost like bumps right before a pimple forms, small and hard, extremely tiny, not very red, sporadic around back and only a few down each arm was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
4 days after receiving the vaccine, I woke up with slight pins and needles sensation; and some numbness in my thumb, index finger and middle finger of my right hand. These sensations gradually increased. Worked Sunday and Monday. On Tuesday, I woke up with those symptoms plus pain in those fingers and an intense burning pain at the base of my right palm. After ibuprofen, it improved some. Went to work. As I was working, pins and needles sensation started in left pinkie finger, ring finger and pinkie finger of right hand. I was advised to go seek medical care. After an assessment, I was told it was carpal tunnel. I have had no prior history of this and I've never experienced these symptoms before. I was given a brace for each wrist.
Very Sore throat, hacking cough, blocked nose - went to Dr. who diagnosed it as a cold on 11/25.  Went to Clinic at on 11/26.  Prescribed amoxycillin plus Benzonatate for cough and Lidocaine gargle.
barely move my arm / arm problem; really bad sore throat; This is a spontaneous report from a contactable consumer (patient). A 27-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number: EW0185, Expiration date was not reported), via an unspecified route of administration on 13May2021 (at the age of 27-years-old) as unknown, single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 14May2021, the patient experienced barely move my arm / arm problem and really bad sore throat. It was reported that the patient was asking if he could take Ibuprofen or Tylenol. The patient also wanted to make sure what he could take for the events. No treatment was received for the events. The outcome of the events was not recovered.   No follow-up attempts are possible. No further information expected.
Neck pain and stiffness-right side (same side as vaccine) started Sunday morning-woke me out of a sound sleep. Can rotate neck slightly to right but can't lean head toward shoulder.
Initial report received from a physician on 05 Apr 2010: This patient was vaccinated with FLUVIRIN (unknown batch no), (dose unspecified), on 01 Apr 2010. The patient was administered with expired vaccine and no adverse reaction occurred. The reporter stated that she "does not want to get into that" and was unable to provide any identifying information about the patient or the vaccine lot number.
Fever (103 lasting a day and a half); Nausea; Chills; Muscle aches and soreness; Malaise; Lymphadenopathy; Arm/under arm/pec soreness in vaccine arm; Fatigue; Sore throat; Dry cough; recevied first dose on 21Dec2020 10:15, then received second dose on 07Jan2021 07:45; recevied first dose on 21Dec2020 10:15, then received second dose on 07Jan2021 07:45; This is a spontaneous report from a contactable nurse (patient). A 27-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number not reported), via intramuscular on 07Jan2021 07:45 at single dose in left arm for covid-19 immunization. The patient had no medical history and no known allergies. Concomitant medication in two weeks included birth control. The patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number not reported), via intramuscular on 21Dec2020 10:15 at single dose in left arm for covid-19 immunization. The patient had no other vaccine in four weeks. No covid tested post vaccination. The patient experienced fever (103 lasting a day and a half), nausea, chills, muscle aches and soreness, malaise, lymphadenopathy and soreness, arm/under arm/pec soreness in vaccine arm, fatigue, sore throat, dry cough on 07Jan2021 19:00. The patient did not receive any treatment for these events. The outcome of the events fever (103 lasting a day and a half), nausea, chills, muscle aches and soreness, malaise, lymphadenopathy and soreness, arm/under arm/pec soreness in vaccine arm, fatigue, sore throat, dry cough was recovered in Jan2021.   Information on the lot/batch number has been requested.
rash; she is itching in every joint; Initial information received on 06-Nov-2023 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp (Non-healthcare professional).  This case involves Elderly female patient who experienced rash and she is itching in every joint after receiving Influenza Quadrival A-B High Dose Hv Vaccine [Fluzone High-Dose Quadrivalent].  The patient's past vaccination(s) included COVID 19 VACCINE. The patient's past medical history, medical treatment(s) and family history were not provided.   On an unknown date in 2023, the patient received an unknown dose of suspect Influenza Quadrival A-B High Dose Hv Vaccine (Frequency: once) (Strength: Standard) (with an unknown formulation, expiry date and lot number) via unknown route in unknown administration site for immunization.  On an unknown date in 2023, the patient developed events of rash and she is itching in every joint (pruritus) (unknown latency).  It was reported, Consumer called stating that she has always gotten the flu shot and starting last year, she got the FLUZONE HD QIV. This year, the FLUZONE HD QIV has caused her to have a rash, the same as the rash she got when she had the COVID-19 vaccine. She was asking of there is anything that they put in the COVID vaccine that is also in the FLUZONE HD QIV. She said that she has been getting the flu shot for a very long time and this time, she is itching in every joint of her body. Consumer said she had the vaccine done at the pharmacy. She said she does not have allergies and she always eat eggs, so she is not sure what was put in the vaccine that caused her to have a rash. Consumer stated that she turned 65 last year which is why she started using the FLUZONE HD QIV. She was upset that the information has to go through an HCP or pharmacist, but she agreed to have them call on her behalf. She said that manufacturers have to let the consumers know what is in the vaccines. The only thing that her pharmacist told her is that there is a new flu variant in this year's vaccine. Consumer was frustrated with the vaccines that she stated she will never take the COVID-19 vaccine again or the FLUZONE HD QIV if it is what's causing her rash.   Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the events.  At time of reporting, the outcome was Unknown for the events
No adverse event, but patient was given second dose of COVID vaccine. Patient previously confirmed that her first dose was Pfizer and then stated later that she had received Moderna dose back in January.
Unable to take second shot as advised by physician; This spontaneous case was reported by a consumer and describes the occurrence of WRONG SCHEDULE (Unable to take second shot as advised by physician) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COPD.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced WRONG SCHEDULE (Unable to take second shot as advised by physician). On 05-Mar-2021, WRONG SCHEDULE (Unable to take second shot as advised by physician) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included On antibiotics for COPD. No relevant concomitant medications were reported.; Sender's Comments: This report refers to a case of wrong technique in product usage process for mRNA-1273 with no associated AEs.
developed a severe rash diagnosed as serum sickness; My 22 month old daughter, whom I am breastfeeding; This is a spontaneous report from a contactable healthcare professional (patient's mother). This healthcare professional reported information for both mother and baby. This is the baby report. Only this case is serious.   A 22-month-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0186), transmammary on 01Oct2021 at 11:00 (at the age of 22-months-old) at dose 2, single for COVID-19 immunisation. The patient's medical history was not reported. Concomitant medications were reported as none. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0186), transmammary on 10Sep2021 at 11:00 at dose 1, single for COVID-19 immunisation. She was breastfed at that time. Facility where the most recent COVID-19 vaccine was administered was reported as school or student health clinic. The patient, who was breastfed, developed a severe rash on 12Oct2021 at 07:00 (also reported as 10 days after the second vaccine dose) diagnosed as serum sickness which was reported to be life-threatening. Serum sickness is an allergic reaction to a serum protein. She had not been sick or received any vaccines or medications during this time period. The event required emergency room/department or urgent care and doctor or other healthcare professional office/clinic visit. She was treated with antihistamines, analgesics, and anti-inflammatory. The outcome of the event was recovering.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the event Serum sickness and BNT162B2.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate. ,Linked Report(s) : US-PFIZER INC-202101383919 maternal case
Patient c/o blisters all over fingers and face x 2 mos after receiving flu vaccine. Also c/o HA the day after receiving flu shot.
After receiving second dose of injection Pfizer vaccine. I begin to experience  side effect including headache, redness, swelling, and tiredness.  1 days later, the condition of those got better but the redness does not go away. My under arm begin to form small red area, very similar to chicken pox. these red area return daily and appear more frequence.
Acute onset of excruciating pain in left arm. Unable to move, lift left arm. Pain causing urge to faint and vomit. Breath holding,  body tenseness. Unable to sleep,  unable to position arm without use of right arm
Information has been received from a nurse practitioner concerning a female pt who in Oct 2006, was vaccinated IM with a dose of HPV Vaccine. Subsequently in Oct 2006, she experienced lightheadedness, weakness, pallor, and sweating, No medical attention was sought. The nurse practitioner indicated the pt was doing fine. No product quality complaint was involved. Additional information has been requested. 01/05/2007 Initial and follow up information has been received from a Nurse Practitioner concerning a 20 year old female patient who in October 2006, was vaccinated IM with a dose of GARDASIL. Subsequently, she experienced nausea, lightheadedness /lightheaded feeling/dizziness, weakness, pallor, and sweating but did not lose consciousness. No medical attention was sought. The nurse practitioner indicated the patient was "doing fine" and that she recovered after 20 minutes. No product quality complaint was involved. Additional information has been requested.
Information has been received from a Licensed Practical Nurse referring to an unspecified number of unspecified patients. On unknown dates in 2015 and 2016 (over the past 3 months) the patient was vaccinated with an unspecified number of doses of ROTATEQ (lot# L027726, expiration date 10-MAY-2017), which were improperly stored at 1 Centigrade for 48 hours (incorrect product storage). No adverse effect reported. There was no previous temperature excursion. The outcome was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
1/30/2021 some itchiness at injection site, small rash that progressively got larger   2/01/21 rash was two distinct rashes, looked like a number 8 2/03/2021 no change in rash, experienced a slight headache, exhaustion and got progressively achy through out the day  2/04/2021 one large rash, no longer experiencing exhaustion, aches or headache  2/05/2021 rash  gone
PATIENT GOT PFIZER AS THE SECOND BOOSTER AFTER GETTING J&J 2 TIMES. PATIENT COULD NOT BREATHE. PATIENT TURNED RED AND WAS NAUSEOUS AND SWEATING. WE CALL 911 AND PATIENT GOT BETTER AFTER 10-15 MINUTES WITHOUT ANY MEDICATION GIVEN. I CALLED TO FOLLOW UP. PATIENT FEELS WELL AND DID NOT HAVE ANY SIDE EFFECTS AFTER THAT.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44-year-old male patient received BNT162b2 (BNT162B2), on 20Apr2021 as dose 1, single (Lot number: ER8732), in left arm, on 12May2021 as dose 2, single (Lot number: EW0173), in left arm and on 12Nov2021 as dose 3 (booster), single (Lot number: EW0186) at the age of 43 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jun2022, outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jun2022) Negative, notes: on days 5, 6; (Jun2022) Positive, notes: test turned positive day 7 and stronger on day 8. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: The patient was not taking any other medications/products within 2 weeks of starting COVID-19 treatment. Anti-viral details: product=COVID 19 Treatment, brand-Paxlovid, treatment start date: 23Jun2022, treatment stop date: 27Jun2022, indication-Treatment of COVID-19.  AE treatment Paxlovid 2nd course, Device Date: 03Jul2022. Reported Event: Completed 5 day course, tested negative on days 5, 6 and then on day 7 symptoms returned and test turned positive day 7 and stronger on day 8. Adverse event start date 30Jun2022
loss of appetite; felt cold; Chills; fever; body aches; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (loss of appetite), FEELING COLD (felt cold), CHILLS (Chills), PYREXIA (fever) and MYALGIA (body aches) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939905, 027B21A and 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.  Concomitant products included EMPAGLIFLOZIN (JARDIANCE), LISINOPRIL, HYDROCHLOROTHIAZIDE, MONTELUKAST, SIMVASTATIN, GLIMEPIRIDE, LEVOTHYROXINE, LEVOTHYROXINE, METOPROLOL, DILTIAZEM, GABAPENTIN and VITAMIN B12 NOS for an unknown indication.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In December 2021, the patient experienced DECREASED APPETITE (loss of appetite), FEELING COLD (felt cold), CHILLS (Chills), PYREXIA (fever), MYALGIA (body aches) and NAUSEA (nausea). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. In December 2021, DECREASED APPETITE (loss of appetite), FEELING COLD (felt cold), CHILLS (Chills), PYREXIA (fever), MYALGIA (body aches) and NAUSEA (nausea) had resolved.            This case was linked to MOD-2021-425598, MOD-2021-425599 (Patient Link).
Pt recv vax on 10/21/98; on 10/25/98 pt exp lightheadedness, woozy, chills, fever, achiness, weakness; 1 wk illness, still weak - washed out